Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS-Induced LH Response in Healthy Women in Luteal Phase

NCT: NCT07363421 · ACTIVE_NOT_RECRUITING

NCT IDNCT07363421
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-24
Completion2026-06-01

Brief Summary

The purpose of this research is to establish whether non-invasive Transcranial Magnetic Stimulation (TMS), can affect modulation of hormones such: Luteinizing Hormone (LH) and Follicle-stimulating hormone (FSH). The hypothesis is that applying TMS to the Dorsolateral Prefrontal Cortex with specific pulse patterns, mimicking endogenous Gonodotropin-Releasing Hormone (GnRH) pulses that are known to stimulate LH secretion may modulate hormonal levels.

Frequently Asked Questions

What is TMS-Induced LH Response in Healthy Women in Luteal Phase?

TMS-Induced LH Response in Healthy Women in Luteal Phase is a clinical trial registered under NCT07363421. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07363421?

The current status of NCT07363421 (TMS-Induced LH Response in Healthy Women in Luteal Phase) is: ACTIVE_NOT_RECRUITING.

When did TMS-Induced LH Response in Healthy Women in Luteal Phase start?

TMS-Induced LH Response in Healthy Women in Luteal Phase started on 2026-02-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.